6518 ORAL Subgroup results from a randomised, double-blind, multicentre phase III study of bevacizumab in combination with cisplatingemcitabine in chemotherapy-naive patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): study BO17704
2007 ◽
Vol 5
(4)
◽
pp. 362
◽
Keyword(s):
Keyword(s):
Keyword(s):
2014 ◽
Vol 32
(15_suppl)
◽
pp. 8056-8056
◽
Keyword(s):
2014 ◽
Vol 32
(15_suppl)
◽
pp. 8046-8046
◽
Keyword(s):
Keyword(s):
Keyword(s):
2019 ◽
Vol 25
(7)
◽
pp. 2088-2095
◽
Keyword(s):
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. LBA7512-LBA7512
◽
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. 7522-7522
◽
Keyword(s):